Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • detrix2015
    Junior Member
    • Jan 2016
    • 1

    MiSeq competition?

    Hi,

    Just doing a little essay on desktop NGS tech and was wondering if anyone could help me out.

    As I understand, the consensus is on the MiSeq system generally for higher throughput and accuracy (homopolymers and indels - still the case?) as compared to the Ion PGM, as well as ease of preparation. With the Ion PGM being the better choice if you have varying amount of samples that need quicker turnaround. With costs essentially the same when it comes down to usable data.

    My questions are two-fold: Does this still apply in terms of RNA-seq specifically? And now with the S5, does this change it at all? Or is it just an ease of use improvement.

    Also, is there any other desktop NGS system that competes in this space currently available?

    Thanks
  • gringer
    David Eccles (gringer)
    • May 2011
    • 845

    #2
    Well, there's the MiniSeq, which is a bit smaller, a bit cheaper (capital cost), and a bit faster, but not really all that useful for people who already have a MiSeq. There's even a competition going for it at the moment:

    Winning laboratories to use next-generation sequencing for entomology, virology, and oncology research


    And, of course, MinION, which currently has an output in the hundreds of megabases for a reasonable flow cell. It's possible Sequel might compete in the low-end high-throughput space as well, depending on how much you are prepared to put down for the sequencer.
    Last edited by gringer; 02-10-2016, 07:53 PM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    214 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    79 views
    0 reactions
    Last Post SEQadmin2  
    Working...